Prognosis, Prognostic Factors and Predictive Factors in Centimeter or Subcentimeter Node-negative Breast Cancer
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35,002
- 试验地点
- 1
- 主要终点
- Breast cancer specific death
研究概览
简要总结
Because of mammography screening increasingly more women are diagnosed with centimeter or subcentimeter node-negative breast cancer (i.e., T1abN0); these tumors account for approximately 19% of all newly diagnosed breast cancers in Sweden. Although the long term relapse-free survival rates among patients with such tumors is as high as ≥90%, some reports suggest that certain patient subgroups may have rates <75%. Firmly established prognostic and predictive factors for patients with T1abN0 tumors are, however, lacking. This is a nationwide, register-based cohort study investigating prognostic and predictive factors in women with centimeter or subcentimeter breast cancer. The study hypotheses are: 1) Established prognostic and/or predictive factors in overall breast cancer are prognostic and/or predictive factors also in centimeter or subcentimeter node-negative breast cancer; 2) The established relative reduction in risk of recurrence and death of adjuvant treatment for overall breast cancer are similar in centimeter or subcentimeter node-negative breast cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 100 Years(Child, Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Operated for centimeter or subcentimeter breast cancer.
排除标准
- •Previous breast cancer.
- •Metastatic breast cancer at diagnosis.
研究组 & 干预措施
Women with T1ab breast cancer.
干预措施: Endocrine therapy (Drug)
Women with T1ab breast cancer.
干预措施: Radiotherapy (Radiation)
Women with T1ab breast cancer.
干预措施: Herceptin (Drug)
Women with T1ab breast cancer.
干预措施: Chemotherapy (Drug)
Women with T1ab breast cancer.
干预措施: Type of breast cancer surgery (Procedure)
Women with T1ab breast cancer.
干预措施: Age at diagnosis (Other)
Women with T1ab breast cancer.
干预措施: Screen detected tumor (Other)
Women with T1ab breast cancer.
干预措施: Menopausal status at diagnosis (Other)
Women with T1ab breast cancer.
干预措施: Tumor size (Other)
Women with T1ab breast cancer.
干预措施: Estrogen receptor (ER) status (Other)
Women with T1ab breast cancer.
干预措施: Tumor grade (Other)
Women with T1ab breast cancer.
干预措施: HER2-status (Other)
Women with T1ab breast cancer.
干预措施: Intrinsic subgroups of breast cancer (Other)
Women with T1ab breast cancer.
干预措施: Nodal status (Other)
结局指标
主要结局
Breast cancer specific death
时间窗: January 1, 1977 to December 31, 2014
次要结局
- Death from any cause(January 1, 1977 to July 30, 2016)
- Metachronous breast cancer(January 1, 1977 to July 30, 2016)
研究者
Andreas Pettersson
Researcher, Principal Investigator
Karolinska Institutet
